Research Study

Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Principal Investigator 
Kim Nguyen Chi

Overview

Body Locations and Systems 
Prostate Cancer
ClinicalTrials.gov# 
NCT03871816
Status 
Recruiting
Study Start/End 
Dec 2, 2019 to Aug 31, 2021
Name/Title 
Lisa Rebane, Clinical Trials Monitor
Phone 
604-877-6000 ext.672655
Purpose of Study 

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC) and to use the variants reported to assess biomarker eligibility for niraparib interventional studies.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.